Documents

in page functions
 

22 December 2014

Gavi and Ebola - FAQ

Gavi and Ebola - Frequently asked questions.

15 December 2014

Pneumococcal AMC OECD GDP Deflator Data

Pneumococcal AMC: OECD GDP Deflator Data Purpose: As per the Pneumococcal AMC Inflation Review Application Process, listed below is the OECD GDP Deflator to be used to calculate an inflation adjustment request. BASE QTR Q2-2009 Q2-2010 Q2-2011 Q2-2012 Q2-2013 Q2-2014 Q2-2015 Q2-2016 Q2-2017 Q2-2018 Q2-2019 Q2-2020 Q2-2

03 December 2014

HPV vaccines - FAQs

Frequently asked question for Human papillomavirus (HPV) vaccines.

03 December 2014

Pneumo and Rota - FAQs

Frequently asked question for Pneumococcal and rotavirus vaccines.

03 December 2014

Men A - FAQs

Frequently asked question for Meningococcal A Conjugate vaccine (Men A).

03 December 2014

IPV - FAQs

Frequently asked question for Inactivated Polio Vaccine (IPV).

03 December 2014

MR vaccines - FAQs

Frequently asked question for Measles-rubella (MR) vaccines.

03 December 2014

YF - FAQs

Frequently asked question for Yellow Fever (YF) vaccines.

28 November 2014

Annex C : IPV Programme Timeline of Activities

Application materials for Inactivated Polio Vaccine (IPV): Timeline of Activities.

28 November 2014

HSS Proposal Form

Application materials for Health system strengthening support – Proposal Form.

27 November 2014

HPV Demonstration Programme Budget and Financing

Application materials for HPV vaccination demonstration programme: Budget and Financing

27 November 2014

HPV Demonstration Programme Timeline

Application materials for HPV vaccination demonstration programme: Timeline

05 November 2014

Gavi meningoccal vaccine support guidelines 2015

Gavi Meningoccal vaccine guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi human papillomavirus vaccine support for national introduction guidelines 2015.

HPV vaccine national guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi pneumoccocal vaccine support guidelines 2015

Gavi pneumococcal vaccine guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi General Guidelines NVS and HSS 2015

General guidelines for Gavi NVS and HSS support, including information on requirements and processes to support application submission in 2015.

05 November 2014

Gavi HSS guidelines 2015

Gavi HSS guidelines, including information on requirements to support application submission in 2015

05 November 2014

Gavi inactivated polio vaccine (IPV) support guidelines 2015

Gavi IPV guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi measles second dose and measles-rubella vaccine support guidelines 2015

Gavi MCV2 and MR vaccine guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi human papillomavirus for demonstration programme guidelines 2015

HPV vaccine demo guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi Japanese encephalitis vaccine support guidelines 2015

Gavi JE vaccine guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi rotavirus vaccine support guidelines 2015

Gavi rotavirus vaccine guidelines outlining requirements and information to support application submission in 2015.

05 November 2014

Gavi yellow fever vaccine support guidelines 2015

Gavi Yellow Fever vaccine guidelines outlining requirements and information to support application submission in 2015.

18 August 2014

GAVI HSS Grant Categorisation 2014

This table is intended to provide ideas of HSS activities to applicants and to allow GAVI to analyse its HSS support by type of grants.

03 July 2014

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response

Process evaluation of Pneumococcal Vaccine Introduction – GAVI Alliance Response.

03 July 2014

Process evaluation report of Pneumococcal Vaccine Introduction in Mozambique, Uganda and Zambia

Process evaluation report of Pneumococcal Vaccine Introduction in Mozambique, Uganda and Zambia.

01 July 2014

GNI per capita 2013

Gross national income per capita 2013.

30 June 2014

Key info on IPV support: dose allocation and VIG amounts calculations

Additional information on GAVI support for IPV.

13 June 2014

Remaining AMC offer amount: June 2014

As of 12 June 2014, the Remaining AMC Offer Amount, corresponding to the AMC funds still available for allocation to industry, is: US $ 405,000,000.

01 May 2014

2014 Pneumococcal AMC Annual Report

This progress report presents an overview of the activities linked to the implementation of the pneumococcal AMC from 1 April 2013 to 31 March 2014. It was developed by the AMC Secretariat at GAVI, in collaboration with the World Bank and UNICEF’s Supply Division, and was approved by the Independent Assessment Committee on 1 May 2014.

24 April 2014

IAC Members

List of IAC members.

31 March 2014

GAVI FCE Annual Progress Report

This report is the first annual progress report for the Full Country Evaluations project. It summarises work done in 2013 and evaluation activities to be taken forward in 2014.

31 March 2014

HSS Country ceilings

Country ceilings and maximum annual amounts for budgeting for GAVI Health Systems Strengthening (HSS) grant applications.

28 March 2014

Pneumo Strategic Demand Forecast - Version 8_0

Published 28 March 2014 PNEUMOCOCCAL CONJUGATE VACCINE Strategic Demand Forecast Version 8.0. This version 8.0 is issued in accordance with the GAVI Forecasting Standard Operating Procedure.

10 March 2014

Delivering results in HSS information sheet

Information sheet about measuring results for health system performance and improving data quality.

10 March 2014

Guidance on GAVI HSS approach and application process

Health system strengthening approach information sheet.

10 March 2014

Performance Based Funding information sheet

Information sheet about GAVI’s HSS Performance Based Funding.

10 March 2014

Human Papillomavirus vaccines information sheet

Human Papillomavirus vaccines information sheet.

10 March 2014

Japanese Encephalitis vaccines FAQ

Japanese Encephalitis vaccines Frequently Asked Questions.

14 February 2014

Overview of the public consultation on supply chain strategy

In July 2013 the GAVI Alliance held a public consultation to seek feedback from global and country stakeholders on a list of supply chain challenges and an emerging strategy framework to address those challenges. The consultation helped us map out and prioritise the activities needed to help strengthen immunization supply chain practices.

 



close icon

modal window here